CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 38 enrolled
Drug / intervention
sertraline +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00835627
NCT00835627Phase 4Completed

Medication and Psychotherapy Treatment Trial for Psychogenic Nonepileptic Seizures

Rhode Island Hospital·interventional·Posted Feb 3, 2009·Updated Nov 10, 2014

In Brief

A Phase 4 clinical trial evaluating sertraline, CBT-ip, and 2 other interventions for Convulsion, Non-Epileptic and 4 related conditions. Completed, enrolled 38 participants across 3 sites.

Detailed Summary

The investigators propose that patients who receive targeted pharmacotherapy (sertraline) or focused psychotherapy (cognitive behavioral therapy-informed psychotherapy (CBT-ip) for NES) or combined treatment (CBT-ip + sertraline) will report fewer nonepileptic seizures (NES) compared to patients who receive community care / treatment as usual (TAU). The purpose of this study is to provide pilot testing and data to inform the future multicenter randomized controlled trial based on the hypothesis.

Study Details

Timeline

Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 3, 2009
Enrollment StartSep 1, 2008
Primary CompletionDec 1, 2012
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 17.4 years ago

Interventions

sertralinedrug

flexible dose sertraline

CBT-ipbehavioral

cognitive behavioral therapy-informed psychotherapy for nonepileptic seizures: 12 individual 1 hour therapy sessions

Combined (sertraline + CBT-ip)other

flexible dose sertraline and cognitive behavioral therapy-informed psychotherapy for nonepileptic seizures: flexible dose sertraline and 12, individual 1 hour therapy sessions

Standard Careother

community care, treatment as usual: routine follow up with existing providers